Skip to main content

Post-IPO Equity Life Science Companies

Explore 3 life science startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
3
Total Funding
$66.1M
Avg Funding
$22.0M
Cities
3

Export 3 Post-IPO Equity Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
London, United Kingdom
$1.1M
raised

GenFlow Biosciences is a biotech company that develops gene therapies for slow or reverse aging in humans and animals.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

La Jolla, United States
$35.0M
raised

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Miami, United States
$30.0M
raised

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Ready to Connect with Post-IPO Equity Life Science Startups?

Get verified founder emails, funding details, and company data for 3 post-ipo equity life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked